Nodular number as a prognostic indicator in hepatic resection for intermediate-stage hepatocellular carcinoma: An international multicenter observational study.
Han Liu(Jilin University), Tian Yang(Second Military Medical University), Yingjian Liang(Harbin Medical University), Matteo Serenari(Azienda USL di Bologna), Guoyue Lv(Jilin University), Wei‐Min Gu(Harbin Medical University), Jie Li(Nanjing University of Chinese Medicine), Zhong Chen(Army Medical University), Cheng-Wu Zhang(Zhejiang Provincial People's Hospital), Zhongqi Fan(Fujian Agriculture and Forestry University), Hong Wang(Liuyang City Maternal and Child Health Hospital), Ya-Hao Zhou(Puer University), Ting‐Hao Chen(National Taiwan University), Ming-Da Wang(Second Military Medical University), Myron Schwartz(Icahn School of Medicine at Mount Sinai), Xianming Wang(Shandong Provincial QianFoShan Hospital), Matteo Cescon(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)
Cited by 0
Related Papers
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Focal Gains of <i>VEGFA</i> and Molecular Classification of Hepatocellular Carcinoma
|Cancer Research|2008|712